(Q33910434)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604269%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604269%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604269%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Katherine J Motyl

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604269%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Laurie K McCauley

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604269%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604269%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cellular Physiology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604269%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604269%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604269%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

1326-1334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604269%20AND%20SRC:MED&resulttype=core&format=json

Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms

1 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Rapamycin impairs trabecular bone acquisition from high-dose but not low-dose intermittent parathyroid hormone treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Streptozotocin, type I diabetes severity and bone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Parathyroid hormone suppresses osteoblast apoptosis by augmenting DNA repair

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Differentiation and proliferation of periosteal osteoblast progenitors are differentially regulated by estrogens and intermittent parathyroid hormone administration

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Low-energy femoral shaft fractures associated with alendronate use.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Understanding the pathology and mechanisms of type I diabetic bone loss.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Molecular and cellular mechanisms of the anabolic effect of intermittent PTH

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Bisphosphonates: from bench to bedside

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

The role of hypoxia inducible factor 1alpha in cobalt chloride induced cell death in mouse embryonic fibroblasts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Simulated microgravity suppresses osteoblast phenotype, Runx2 levels and AP-1 transactivation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

MLO-Y4 osteocyte-like cells support osteoclast formation and activation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Bisphosphonates: from the laboratory to the clinic and back again

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Factors influencing height and weight development in children with diabetes. Results of the Berlin Retinopathy Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Anabolic actions of parathyroid hormone on bone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Effects of Diabetes Mellitus on Bone Mass in Juvenile and Adult-Onset Diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study

5 July 2018

1 reference

Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism

21 January 2018

1 reference

Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys

21 January 2018

1 reference

The bone marrow microenvironment contributes to type I diabetes induced osteoblast death

21 January 2018

1 reference

Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism

21 January 2018

1 reference

The effects of local insulin delivery on diabetic fracture healing

21 January 2018

1 reference

Age at onset and long-term metabolic control affect height in type-1 diabetes mellitus

21 January 2018

1 reference

Possible association between diabetes and bisphosphonate-related jaw osteonecrosis.

21 January 2018

1 reference

Intermittent parathyroid hormone fails to stimulate osseointegration in diabetic rats.

21 January 2018

1 reference

Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate

21 January 2018

1 reference

Role of parathyroid hormone-related protein in the decreased osteoblast function in diabetes-related osteopenia

21 January 2018

1 reference

Type I diabetic bone phenotype is location but not gender dependent.

21 January 2018

1 reference

Bone inflammation and altered gene expression with type I diabetes early onset

21 January 2018

1 reference

Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice

21 January 2018

1 reference

Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells.

21 January 2018

1 reference

Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose

21 January 2018

1 reference

Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals

21 January 2018

1 reference

Delayed remodeling in the early period of fracture healing in spontaneously diabetic BB/OK rats depending on the diabetic metabolic state

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100799

Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats

29 October 2018

1 reference

12 December 2020

Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety

1 reference

12 December 2020

Enhancement of Experimental Fracture-Healing by Systemic Administration of Recombinant Human Parathyroid Hormone (PTH 1-34)

1 reference

12 December 2020

Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization

1 reference

12 December 2020

Effects of parathyroid hormone (1-34) on tibia in an adult rat model for chronic alcohol abuse

1 reference

12 December 2020

Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength

1 reference

12 December 2020

Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone

1 reference

12 December 2020

Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation

1 reference

12 December 2020

Inhibition of PPARγ prevents type I diabetic bone marrow adiposity but not bone loss

1 reference

12 December 2020

Bone Loss and Increased Bone Adiposity in Spontaneous and Pharmacologically Induced Diabetic Mice

1 reference

12 December 2020

Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways

1 reference

12 December 2020

Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats

1 reference

12 December 2020

Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats

1 reference

12 December 2020

Histomorphometric evaluation of the recovering effect of human parathyroid hormone (1-34) on bone structure and turnover in streptozotocin-induced diabetic rats

1 reference

12 December 2020

Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus

1 reference

12 December 2020

Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology

1 reference

12 December 2020

Anabolic Actions of Parathyroid Hormone on Bone*

1 reference

12 December 2020

Identifiers

DOI

10.1002/JCP.22844

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604269%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604269%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

PubMed publication ID

21604269

1 reference